Document is current
Any future updates will be listed below
-
Authors
Bowden, Rory
Davies, Robert W.
Heger, Andreas
Pagnamenta, Alistair T.
de Cesare, Mariateresa http://orcid.org/0000-0002-9847-1526
Oikkonen, Laura E.
Parkes, Duncan http://orcid.org/0000-0003-2811-1637
Freeman, Colin
Dhalla, Fatima
Patel, Smita Y. http://orcid.org/0000-0002-6207-2208
Popitsch, Niko
Ip, Camilla L. C.
Roberts, Hannah E. http://orcid.org/0000-0001-5738-4111
Salatino, Silvia http://orcid.org/0000-0003-1286-3076
Lockstone, Helen
Lunter, Gerton http://orcid.org/0000-0002-3798-2058
Taylor, Jenny C. http://orcid.org/0000-0003-3602-5704
Buck, David
Simpson, Michael A.
Donnelly, Peter http://orcid.org/0000-0001-9495-3408
- License Information
-
More Information
Article History
Received: 30 August 2018
Accepted: 19 March 2019
First Online: 23 April 2019
Competing interests
: R.B., G.L. and D.B. have been members of the MinION access program (MAP) in connection with which they have received free-of-charge flow cells from Oxford Nanopore Technologies. The Wellcome Centre for Human Genetics has been a member of Oxford Nanopore’s PromethION early access program. R.W.D., A.H., G.L., M.A.S. and P.D. are or have been employees of Genomics plc. The remaining authors declare no competing interests.
